Strikingly, in order to apply this finding to the clinical treatment of PDT-targeted anti-lung cancer, they conducted the first in vivo dose-efficacy and safety experiment with a photosensitor (VII/NLS-SnCe6) chimeric with mouse factor VII protein, a natural ligand of TF. Here, TF is linked to lung carcinoma.